Sitari Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Sitari Pharmaceuticals?

Sitari Pharmaceuticals has 2 investors including GlaxoSmithKline And Avalon Ventures.

Q: How much funding has Sitari Pharmaceuticals raised to date?

Sitari Pharmaceuticals has raised obfuscated.

Overview

Sitari Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Sitari Pharmaceuticals

CB Rank

768618

Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.

Acquired by

GlaxoSmithKline

Founded

obfuscation

Private

Series A

San Diego, California, United States

Biopharma

Biotechnology

Health Care

Intellectual Property

Pharmaceutical

Robotics

Funding Rounds

Series A

OBF

obfuscation

Key People

Chaitan S. Khosla: Founder
Past Role: Kosan Biosciences, Founder & Co-Chairman

Details

Legal Name

Sitari Pharma Inc.

Operating Status

Active

Company Type

For Profit

Founders

Chaitan S. Khosla

About the Company

Sitari Pharmaceuticals is a operator of a biotechnology company intended to develop treatments for multiple disease indications with an initial focus in celiac disease.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Sitari Pharmaceuticals	2	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
GlaxoSmithKline	—	Series A - Sitari Pharmaceuticals	—
GlaxoSmithKline	—	Series A - Sitari Pharmaceuticals	—
GlaxoSmithKline	—	Series A - Sitari Pharmaceuticals	—
GlaxoSmithKline	—	Series A - Sitari Pharmaceuticals	—
GlaxoSmithKline	—	Series A - Sitari Pharmaceuticals	—